MeSH term
Frequency | Condition_Probility | *Amino Acid Transport System y+ | 2 | 50.0 |
Analysis of Variance | 2 | 0.0 |
Animals | 78 | 0.0 |
Biological Transport | 2 | 0.0 |
Cell Line | 27 | 0.0 |
Cell Membrane/metabolism | 5 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Humans | 136 | 0.0 |
Kinetics | 7 | 0.0 |
Protein Binding | 10 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 71 | 0.0 |
Time Factors | 13 | 0.0 |
Infant | 4 | 0.0 |
Molecular Sequence Data | 21 | 0.0 |
Molecular Weight | 2 | 0.0 |
Phosphorylation | 20 | 0.0 |
Platelet Activation/*drug effects | 2 | 3.0 |
Research Support, Non-U.S. Gov't | 89 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
*Adaptor Proteins, Signal Transducing | 31 | 2.0 |
Carrier Proteins/physiology | 3 | 2.0 |
Phosphoproteins/physiology | 3 | 5.0 |
Receptors, Antigen, T-Cell/*physiology | 4 | 2.0 |
Signal Transduction/*physiology | 6 | 0.0 |
*Apoptosis | 4 | 0.0 |
Herpesvirus 1, Human/*genetics | 7 | 26.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
*Transcription, Genetic | 11 | 0.0 |
Virus Latency/*genetics | 13 | 81.0 |
Disease Models, Animal | 9 | 0.0 |
Herpesvirus 1, Human/genetics/*physiology | 8 | 53.0 |
Introns | 3 | 0.0 |
Keratitis, Herpetic/virology | 4 | 80.0 |
Rabbits | 17 | 0.0 |
Virus Activation/*drug effects | 2 | 18.0 |
*Virus Latency | 18 | 36.0 |
Adult | 22 | 0.0 |
Aged | 13 | 0.0 |
Comparative Study | 9 | 0.0 |
English Abstract | 6 | 0.0 |
Female | 33 | 0.0 |
Male | 25 | 0.0 |
Middle Aged | 17 | 0.0 |
Gene Expression | 7 | 0.0 |
Genome, Viral | 4 | 3.0 |
Keratitis, Herpetic/*virology | 2 | 66.0 |
Mice | 43 | 0.0 |
RNA, Viral | 2 | 4.0 |
Trigeminal Ganglion/pathology/virology | 2 | 100.0 |
Viral Proteins/*genetics | 5 | 6.0 |
Virus Activation | 7 | 13.0 |
Virus Replication | 11 | 1.0 |
In Vitro | 3 | 0.0 |
Interleukin-2/genetics | 2 | 2.0 |
Jurkat Cells | 20 | 1.0 |
Lymphocyte Activation | 13 | 0.0 |
Membrane Microdomains/metabolism | 2 | 6.0 |
*Membrane Proteins | 23 | 2.0 |
Models, Biological | 5 | 0.0 |
Mutagenesis, Site-Directed | 5 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
Oxidative Stress | 2 | 0.0 |
Protein Conformation | 2 | 0.0 |
Receptors, Antigen, T-Cell/*metabolism | 6 | 4.0 |
Signal Transduction | 16 | 0.0 |
Transfection | 10 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 2 | 0.0 |
Carrier Proteins/metabolism | 8 | 1.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Enzyme Activation | 8 | 0.0 |
Isoenzymes/metabolism | 6 | 1.0 |
Jurkat Cells/immunology | 2 | 33.0 |
Macromolecular Substances | 2 | 0.0 |
*Nuclear Proteins | 4 | 0.0 |
Phospholipase C/metabolism | 7 | 2.0 |
Phosphoproteins/metabolism | 7 | 1.0 |
Protein Processing, Post-Translational | 3 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 7 | 0.0 |
Sequence Deletion | 6 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
5' Untranslated Regions/genetics | 2 | 1.0 |
Acute Disease | 2 | 0.0 |
Hela Cells | 6 | 0.0 |
Herpes Simplex/pathology/virology | 2 | 100.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Transcription, Genetic/genetics | 3 | 0.0 |
Base Sequence | 20 | 0.0 |
COS Cells | 5 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 9 | 0.0 |
Antigens, CD3/metabolism | 2 | 1.0 |
Cells, Cultured | 14 | 0.0 |
Receptors, Antigen, T-Cell/metabolism | 10 | 5.0 |
*RNA Splicing | 2 | 0.0 |
Carrier Proteins/*metabolism | 7 | 0.0 |
Flow Cytometry | 4 | 0.0 |
Immunoblotting | 2 | 0.0 |
Phosphoproteins/*metabolism | 6 | 1.0 |
Precipitin Tests | 5 | 0.0 |
Tyrosine/metabolism | 12 | 1.0 |
Blood Platelets/metabolism | 2 | 1.0 |
Protein Structure, Tertiary | 5 | 0.0 |
*Signal Transduction | 6 | 0.0 |
T-Lymphocytes/metabolism | 3 | 1.0 |
Antigens, CD/biosynthesis | 2 | 0.0 |
Antigens, Differentiation, T-Lymphocyte/biosynthesis | 2 | 2.0 |
Binding Sites | 12 | 0.0 |
Blotting, Western | 5 | 0.0 |
Hybridomas/metabolism | 2 | 9.0 |
Interleukin-2/biosynthesis | 2 | 0.0 |
Mutation | 8 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 3 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
src Homology Domains | 4 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Immediate-Early Proteins/metabolism | 2 | 6.0 |
In Situ Hybridization | 8 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Virus Latency/genetics | 4 | 36.0 |
Plaque Assay | 2 | 2.0 |
Transcription, Genetic | 15 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Enzyme Precursors/metabolism | 3 | 2.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Platelet Aggregation/drug effects | 2 | 0.0 |
Signal Transduction/*drug effects | 2 | 0.0 |
T-Lymphocytes/drug effects/*metabolism | 2 | 4.0 |
Mice, Inbred BALB C | 10 | 0.0 |
Phenotype | 5 | 0.0 |
*RNA, Viral | 3 | 23.0 |
Antigens, CD3/immunology/metabolism | 2 | 11.0 |
Carrier Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
Phosphoproteins/chemistry/genetics/*metabolism | 2 | 4.0 |
Proteins/metabolism | 3 | 0.0 |
*Gene Deletion | 2 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Mutagenesis | 3 | 0.0 |
Phosphoproteins/*genetics | 2 | 0.0 |
T-Lymphocytes/*metabolism | 4 | 1.0 |
Oncogene Proteins/metabolism | 2 | 2.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Green Fluorescent Proteins | 5 | 0.0 |
Luminescent Proteins/genetics | 2 | 1.0 |
*Open Reading Frames | 2 | 5.0 |
RNA, Viral/*biosynthesis | 4 | 19.0 |
Cercopithecus aethiops | 13 | 1.0 |
Gene Expression Regulation, Viral | 4 | 1.0 |
Neurons/*virology | 3 | 37.0 |
Vero Cells | 12 | 5.0 |
*Virus Activation | 4 | 12.0 |
Amino Acid Sequence | 5 | 0.0 |
T-Lymphocytes/immunology/metabolism | 3 | 2.0 |
DNA, Viral/analysis | 4 | 1.0 |
Herpes Simplex/*virology | 3 | 60.0 |
Herpesvirus 1, Human/*physiology | 4 | 30.0 |
Herpesvirus 3, Human/*physiology | 2 | 100.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Trigeminal Ganglion/*virology | 3 | 75.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
*Lymphocyte Activation | 2 | 0.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
T-Lymphocytes/*immunology | 3 | 0.0 |
Cytomegalovirus/genetics | 2 | 2.0 |
Genes, Reporter | 2 | 0.0 |
*Genes, Viral | 6 | 3.0 |
Lac Operon | 3 | 2.0 |
*Promoter Regions (Genetics) | 13 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Herpesvirus 1, Human/*genetics/physiology | 9 | 81.0 |
Neurons/virology | 3 | 30.0 |
Trigeminal Ganglion/virology | 11 | 91.0 |
Virulence/genetics | 3 | 4.0 |
Phospholipase C/*metabolism | 2 | 1.0 |
Tyrosine/*metabolism | 2 | 0.0 |
Membrane Lipids/*physiology | 2 | 16.0 |
T-Lymphocytes/*physiology | 2 | 0.0 |
Phosphotyrosine/metabolism | 2 | 0.0 |
Membrane Proteins/*physiology | 2 | 1.0 |
Saccharomyces cerevisiae | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Phosphoproteins/genetics/*metabolism | 2 | 1.0 |
Killer Cells, Natural/*immunology | 2 | 0.0 |
Muromonab-CD3/pharmacology | 2 | 2.0 |
Blotting, Southern | 6 | 0.0 |
Virus Activation/*genetics | 4 | 57.0 |
*DNA-Binding Proteins | 2 | 0.0 |
*Gene Expression Regulation, Viral | 8 | 2.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
Tissue Distribution | 2 | 0.0 |
*Latex Fixation Tests | 3 | 37.0 |
Sensitivity and Specificity | 4 | 0.0 |
Rats | 6 | 0.0 |
Genes, Viral | 3 | 1.0 |
Mice, Transgenic | 3 | 0.0 |
*Ubiquitin-Protein Ligases | 2 | 0.0 |
Virulence | 4 | 1.0 |
B-Lymphocytes/*immunology | 2 | 0.0 |
DNA Replication | 2 | 0.0 |
Virus Latency | 9 | 15.0 |
Mice, Inbred ICR | 2 | 0.0 |
Child | 3 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Adrenergic Agonists/pharmacology | 2 | 28.0 |
Epinephrine/pharmacology | 3 | 3.0 |
Herpesvirus 1, Human/*genetics/growth & development/physiology | 2 | 100.0 |
Virus Activation/drug effects/*genetics | 3 | 100.0 |
Neuroblastoma | 2 | 1.0 |
beta-Galactosidase/genetics | 2 | 1.0 |
DNA Primers | 5 | 0.0 |
*Immediate-Early Proteins | 3 | 1.0 |
TATA Box | 2 | 0.0 |
Herpes Simplex/pathology/*virology | 2 | 100.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
*Regulatory Sequences, Nucleic Acid | 3 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
TATA Box/genetics | 2 | 4.0 |
Phosphatidylcholine-Sterol O-Acyltransferase/*metabolism | 2 | 3.0 |
Lipoproteins, LDL/blood | 2 | 0.0 |
DNA, Viral | 3 | 1.0 |
Guinea Pigs | 2 | 0.0 |
Herpesvirus 2, Human/*genetics/physiology | 2 | 100.0 |
RNA, Viral/metabolism | 2 | 2.0 |
Recurrence | 3 | 0.0 |
Culture Techniques | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Exercise Test | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
RNA, Messenger/*genetics | 2 | 0.0 |
RNA, Viral/genetics | 2 | 2.0 |
Simplexvirus/*genetics | 4 | 14.0 |
RNA, Viral/*analysis | 2 | 3.0 |
Chloramphenicol O-Acetyltransferase/genetics/metabolism | 2 | 1.0 |
Child, Preschool | 3 | 0.0 |
Restriction Mapping | 4 | 0.0 |
Simplexvirus/genetics/*physiology | 2 | 66.0 |
Infant, Newborn | 2 | 0.0 |
Simplexvirus/genetics/*isolation & purification | 2 | 100.0 |
Cell Survival | 2 | 0.0 |
DNA, Viral/genetics | 2 | 1.0 |
Oligonucleotide Probes | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Herpes Simplex/genetics | 2 | 50.0 |
Simplexvirus/enzymology/*genetics | 2 | 25.0 |
Thymidine Kinase/*genetics | 2 | 4.0 |
Oxygen Consumption | 3 | 1.0 |
Ganglia/*microbiology | 2 | 100.0 |
Herpes Simplex/*microbiology | 2 | 66.0 |
Neurons, Afferent/*microbiology | 2 | 100.0 |
1-Acylglycerophosphocholine O-Acyltransferase/*blood | 4 | 80.0 |
Acyltransferases/*blood | 4 | 28.0 |
Lipoproteins, VLDL/pharmacology | 2 | 12.0 |
Phosphatidylcholine-Sterol O-Acyltransferase/*blood | 2 | 1.0 |
Calcium/metabolism | 3 | 0.0 |
Mice, Knockout | 2 | 0.0 |
*Platelet Aggregation | 2 | 2.0 |
src-Family Kinases/metabolism | 2 | 1.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Energy Metabolism | 2 | 1.0 |
*Exertion | 2 | 1.0 |
Signal Transduction/*immunology/physiology | 2 | 66.0 |
Microscopy, Confocal | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Lipoproteins, LDL/*pharmacology | 2 | 3.0 |
Cholesterol/blood | 2 | 0.0 |
Phosphatidylcholine-Sterol O-Acyltransferase/blood | 2 | 2.0 |
Luminescent Proteins/metabolism | 3 | 0.0 |
Membrane Microdomains/*physiology | 2 | 10.0 |
